Viatris UK Healthcare Ltd

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2026	5	Value not published	5
2025	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierViatris UK Healthcare Ltd

Source records

Published awards

Page 1 of 2 · 27 records.

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Buyer: NHS England
End date in notice
31 Aug 2028Date from the linked contract
Value shown in notice
£665,389,588Value from the linked contract
Official source
Open the official Find a Tender notice for NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
ocds-h6vhtk-051c98 / 3
NHS National Generics Pharmaceuticals - Supply Chain Resilience Lot 2 Hospital Only products
Buyer: NHS England

Viatris UK Healthcare Ltd

Published records by year

Buyer relationships by value counted

Published awards

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

NHS National Generics Pharmaceuticals - Supply Chain Resilience Lot 2 Hospital Only products

NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide

Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products

NHS National Branded Interim - 1 June 2026

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

NHS National Framework for Generics Housekeeping - Lot 2 Hospital Only products

Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Clozapine Tablets (Core)

Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)

Medicinal Products - Direct to Trust

Medicinal Products - with Pharma Funded Homecare Services

Dasatinib Tablets

Antiretroviral Drugs

Proprietary Drugs

Direct Acting Oral Anticoagulants (DOACs)

All Other Cardiovascular & Respiratory Medicines